Timothy A. Yap has been appointed as Editor-in-Chief of Clinical Cancer Research

About the role

The American Association for Cancer Research (AACR) has announced the appointment of Timothy A. Yap, MBBS, PhD, as the new Editor-in-Chief of Clinical Cancer Research.

Responsibilities

• Enhance understanding of cancer biology and translate insights into transformative patient outcomes through innovative biomarker-driven trials and other clinically relevant studies.
• Lead the AACR Special Conferences Committee, Clinical Trials Advisory Council, and Task Force on Precision Combination Therapy.
• Co-chair the AACR Annual Meeting Clinical Trials Committee and Program Committee.
• Contribute to the AACR Exploratory IND/Phase 0 Clinical Trials Task Force and Cancer Progress Report Steering Committee.
• Accelerate clinical studies of molecularly targeted agents and immunotherapies through novel predictive and pharmacodynamic biomarkers.

Requirements

Timothy A. Yap, MBBS, PhD, is a Medical Oncologist and Physician-Scientist at the University of Texas MD Anderson Cancer Center. He holds various leadership and advisory positions within the AACR and has extensive experience in clinical research and translational medicine.

Qualifications

• BSc degree with First-Class Honors in Immunology and Infectious Diseases from Imperial College London.
• Medical degree from Imperial College London and general medical training in Oxford.
• Vast expertise in clinical research and translational medicine.
• Leadership roles in the AACR, including chairing committees and serving on task forces.
• Experience in clinical trials and biomarker-driven studies.
• Award-winning researcher with multiple recognitions in clinical and translational research.

Skills

• Expertise in clinical research and translational medicine.
• Strong background in molecular targeted agents and immunotherapies.
• Experience in leading clinical trials and translational research.
• Ability to bridge laboratory discoveries with clinical applications.

Benefits

Clinical Cancer Research is dedicated to publishing innovative clinical and translational cancer research that bridges laboratory discoveries with clinical applications. The journal prioritizes clinical trials that assess new treatments, along with research on pharmacology, molecular alterations, and biomarkers that predict responses or resistance to treatment.

Pay

Details about pay are not specified in the provided information.

Schedule

Details about the schedule are not specified in the provided information.